Phase IIa Clinical Study of N-Rephasin® SAL200
Clinical trial NCT03089697 · TERMINATED
Trial details
- NCT number
- NCT03089697
- Sponsor
- Intron Biotechnology, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-07
- Primary completion
- 2019-11-07
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.